Computational Biology

Global Computational Biology Market to Reach US$28.6 Billion by 2030

The global market for Computational Biology estimated at US$10.5 Billion in the year 2024, is expected to reach US$28.6 Billion by 2030, growing at a CAGR of 18.1% over the analysis period 2024-2030. Contract Services, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$20.1 Billion by the end of the analysis period. Growth in the In-House Services segment is estimated at 15.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 17.0% CAGR

The Computational Biology market in the U.S. is estimated at US$3.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 17.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 15.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Computational Biology Market - Key Trends and Drivers Summarized

How Is Computational Biology Transforming Research and Innovation in Life Sciences?

Computational biology is revolutionizing the field of life sciences by applying mathematical models, algorithms, and data analysis techniques to biological data, helping researchers unlock complex biological processes that were previously inaccessible. This interdisciplinary field integrates biology, computer science, and mathematics to solve biological problems, ranging from understanding gene expression and protein interactions to simulating the behavior of entire biological systems. Computational biology plays a critical role in modern research, especially in genomics, proteomics, systems biology, and drug discovery. It allows scientists to analyze large datasets—such as the human genome or microbiome data—rapidly and with unprecedented accuracy, leading to breakthroughs in personalized medicine, disease modeling, and evolutionary biology. As biological data continues to grow exponentially, the importance of computational biology increases, providing researchers with the tools to extract meaningful insights, develop new therapies, and understand the underlying mechanisms of life at the molecular and systemic levels.

What Technological Advancements Are Driving Computational Biology?

The field of computational biology has seen significant advances, largely driven by technological innovations that have expanded its capacity to handle and interpret vast amounts of biological data. One of the most influential technologies is next-generation sequencing (NGS), which has drastically reduced the time and cost required to sequence DNA and RNA, generating massive datasets that computational biology tools can process to uncover genetic variations, mutations, and patterns. Coupled with advancements in high-performance computing (HPC), researchers can now analyze complex biological networks and large datasets in a fraction of the time previously required. Artificial intelligence (AI) and machine learning are also transforming computational biology, enabling predictive modeling, pattern recognition, and automated hypothesis generation in areas such as drug discovery and personalized medicine. AI algorithms can sift through massive biological datasets to predict drug-target interactions, patient responses to treatments, and even the emergence of disease outbreaks. Additionally, cloud computing has made computational biology more accessible by providing scalable resources for data storage and processing, fostering collaboration across global research teams. These advancements have greatly accelerated research, allowing for more sophisticated models of biological systems, faster drug discovery, and deeper insights into complex diseases.

How Is Computational Biology Applied Across Different Research Areas?

Computational biology is applied across numerous fields within the life sciences, playing a pivotal role in genomics, drug discovery, systems biology, and evolutionary biology. In genomics, computational tools are used to sequence and analyze entire genomes, providing insights into genetic disorders, evolution, and individual responses to drugs, which form the foundation of personalized medicine. By identifying genetic variants and predicting their impact on protein function, computational biology enables researchers to better understand the genetic basis of diseases like cancer, Alzheimer’s, and diabetes. In drug discovery, computational models simulate how drug candidates interact with biological targets, significantly reducing the time and cost required for laboratory testing. These models help predict the efficacy and safety of potential therapies before they enter clinical trials, streamlining the drug development pipeline. In systems biology, computational approaches are used to model entire biological systems—such as metabolic pathways or cellular processes—to understand how interactions between genes, proteins, and metabolites lead to complex behaviors in organisms. This holistic understanding is crucial for identifying potential therapeutic targets and for developing treatments for multifactorial diseases. Evolutionary biology also benefits from computational biology, where large-scale datasets allow researchers to trace the evolutionary history of species, understand the impact of natural selection on genomes, and predict how organisms might adapt to environmental changes. Across these diverse fields, computational biology enables scientists to make sense of biological complexity and translate data into actionable insights.

What Factors Are Driving the Growth of the Computational Biology Market?

The growth in the computational biology market is driven by several key factors, reflecting both technological advancements and evolving research needs. One of the primary drivers is the increasing volume and complexity of biological data being generated from next-generation sequencing (NGS), CRISPR gene editing, and other advanced biotechnologies. As the cost of sequencing continues to drop, more researchers and institutions are generating large datasets that require sophisticated computational tools to analyze and interpret, fueling the demand for computational biology solutions. Another important factor is the rise of personalized medicine, which relies heavily on computational models to analyze genetic information and tailor treatments to individual patients based on their unique genetic profiles. This shift towards precision medicine is creating new opportunities for computational biology in drug discovery, diagnostics, and treatment planning. Additionally, the growing use of artificial intelligence (AI) and machine learning in life sciences is accelerating the adoption of computational biology, as these technologies provide powerful tools for identifying patterns, predicting outcomes, and optimizing research strategies. The increasing integration of computational biology with bioinformatics and biotechnology industries, particularly in pharmaceutical and biotechnology companies, is also a major growth driver, as businesses seek to leverage computational tools to expedite drug discovery and reduce R&D costs. Furthermore, the need for better disease modeling, especially in light of global health challenges such as pandemics, is pushing researchers and healthcare institutions to invest in computational biology to predict disease outbreaks, model epidemiological trends, and develop new treatments more rapidly. Lastly, government and academic funding for genomics research and life sciences innovation is further propelling the growth of the computational biology market, as public and private sectors recognize its potential to revolutionize healthcare, agriculture, and environmental management. These factors collectively underscore the rapid expansion of computational biology, as it becomes an essential tool for solving some of the most pressing challenges in modern science and medicine.

SCOPE OF STUDY:

The report analyzes the Computational Biology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Service (Contract Services, In-House Services); Application (Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development, Human Body Simulation Software); End-Use (Commercial, Academics, Industrial)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

• Certara LP
• Chemical Computing Group ULC
• Compugen Ltd.
• Dassault Systemes
• Genedata AG
• Insilico Biotechnology AG
• Leadscope, Inc.
• Nimbus Therapeutics
• Rosa & Co. LLC
• Schrodinger LLC
• Simulations Plus, Inc.
• Strand Life Sciences Pvt., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs CBob geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.